| 29.6 -0.54 (-1.79%) | 08-28 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 44.48  |
1-year : | 51.08 |
| Resists | First : | 38.08 |
Second : | 43.74 |
| Pivot price | 38.95 |
|||
| Supports | First : | 28.93 |
Second : | 24.06 |
| MAs | MA(5) : | 34.22 |
MA(20) : | 39.7 |
| MA(100) : | 36.19 |
MA(250) : | 29.98 |
|
| MACD | MACD : | -2.2 |
Signal : | -0.9 |
| %K %D | K(14,3) : | 2.6 |
D(3) : | 6.9 |
| RSI | RSI(14): 19.7 |
|||
| 52-week | High : | 47.4 | Low : | 23.01 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ELMD ] has closed below the lower bollinger band by 3.5%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 141.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 30.71 - 30.92 | 30.92 - 31.09 |
| Low: | 28.39 - 28.67 | 28.67 - 28.88 |
| Close: | 29.21 - 29.59 | 29.59 - 29.89 |
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Fri, 28 Aug 2026
Electromed, Inc. Common Stock (NYSE:ELMD) Stock Quote - The Chronicle-Journal
Fri, 28 Aug 2026
Price to book forward of Electromed, Inc. – AMEX:ELMD - TradingView
Fri, 28 Aug 2026
Electromed: Contrarian 'Buy' With SmartVest (NYSE:ELMD) - Seeking Alpha
Wed, 26 Aug 2026
Electromed Inc (ELMD) Shares Fall 19.2% -- GF Value Says Still O - GuruFocus
Wed, 26 Aug 2026
Electromed Inc (ELMD) (Q4 2026) Earnings Call Highlights: Record Revenue and 15th Consecutive ... By GuruFocus - Investing.com Canada
Wed, 26 Aug 2026
Electromed (ELMD) Stock Reprices As Hospital Weakness Clouds Growth Story - Sahm
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|